Delivery Order SPE2D021DA002-SPE2D326F0626
- Not listed
- The Defense Logistics Agency, through its Medical Supply Chain function, awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Epinephrine 0.3 mg auto-injector two-packs. The contract, valued at $1,742.50 with an ultimate completion date of August 25, 2025, was awarded on August 20, 2025, on a firm fixed-price basis with no set-aside designation. The vendor will perform deliveries from its Park Ridge, Illinois facility. This...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector units (quantity 2). This firm fixed-price delivery order, valued at $1,742.50, was issued on October 2, 2025, with an ultimate completion date of October 3, 2025, and does not include a set-aside designation. The order will be fulfilled from the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 29, 2025, for epinephrine 0.3 mg auto-injector supplies (2-pack) valued at $1,219.75. This firm fixed-price delivery order, issued without set-aside designation, supports the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of September 30, 2025. The award is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency (DLA), acting under the Medical Supply Chain, awarded a delivery order to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 2, 2025, has a ceiling value of $1,916.75 and is scheduled for completion by October 3, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents performance by the vendor from its location in Park Ridge, Illinois. DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,742.50 by the Defense Logistics Agency's Medical Supply Chain division on September 2, 2025. The contract calls for the delivery of Epinephrine 0.3 mg auto-injector units (2-pack) to support federal healthcare operations. The delivery order carries an ultimate completion date of September 5, 2025, and represents...
- The U.S. Defense Logistics Agency Medical Supply Chain issued a firm fixed-price delivery order valued at $1,394.00 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is expected to be completed by September 5, 2025, and represents performance at the vendor's Park...
- The U.S. Department of Defense Medical Supply Chain issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine auto-injectors. The delivery order, valued at $1,329.28 with a firm fixed-price structure, was awarded on October 15, 2025, with an ultimate completion date of October 27, 2025. This award carries no set-aside designation, demonstrating the contractor's competitive standing...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of epinephrine auto-injectors. This firm fixed-price delivery order, valued at $2,326.24, was issued on March 4, 2025, with an ultimate completion date of March 14, 2025. The award carries no set-aside designation, and performance will take place at the contractor's Park Ridge...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. for Epinephrine 0.3 mg auto-injector units (2-pack configuration) with a ceiling value of $1,394.00. The award, issued on July 23, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 28, 2025. This delivery order was issued without set-aside designation and is being fulfilled at the contractor's facility in...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,983.53 to DMS Pharmaceutical Group Inc. for the supply of Epinephrine 0.3 mg auto-injector two-packs. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, and performance to be fulfilled in...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D326F0626Delivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a $3,833.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of epinephrine 0.3 mg auto-injector 2-packs. The award, issued on October 16, 2025, with an ultimate completion date of October 17, 2025, was made without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded on November 13, 2025, that positions the company as a regional prime vendor contractor supporting Department of Defense pharmaceutical supply needs. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated substantial contracting activity across multiple therapeutic categories and product lines, including emergency medications, specialty pharmaceuticals, biologics, vaccines, and routine pharmaceuticals. The PPV-G GEN V contract, structured with a 30-month base period and three 30-month option periods through December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products to support recurring medical supply needs of military healthcare facilities worldwide. This delivery order for epinephrine auto-injectors represents one component of the vendor's broader role as a pharmaceutical supplier for Department of Defense healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 10/16/25 |